Intersect ENT Reports Second Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Intersect ENT (XENT) Tops Q2 EPS by 3c, FY Revenue Guidance Misses
August 1, 2018 8:41 AM EDTIntersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.15 million.
Outlook
The company expects to achieve third quarter revenue in the range of $23.8 to $24.3 million,... More
